BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 31281318)

  • 1. Tertiary Lymphoid Organs in Cancer Immunology: Mechanisms and the New Strategy for Immunotherapy.
    Lin L; Hu X; Zhang H; Hu H
    Front Immunol; 2019; 10():1398. PubMed ID: 31281318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Tertiary Lymphoid Structures for Tumor Immunotherapy.
    Tang H; Qiu X; Timmerman C; Fu YX
    Methods Mol Biol; 2018; 1845():275-286. PubMed ID: 30141019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tertiary lymphoid structures in the era of cancer immunotherapy.
    Sautès-Fridman C; Petitprez F; Calderaro J; Fridman WH
    Nat Rev Cancer; 2019 Jun; 19(6):307-325. PubMed ID: 31092904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intratumoral B cells and tertiary lymphoid structures are biomarkers of survival and immunotherapy responses].
    Fridman WH; Petitprez F; Sautes-Fridman C
    Bull Cancer; 2020 Apr; 107(4):403-404. PubMed ID: 32284150
    [No Abstract]   [Full Text] [Related]  

  • 5. The Crohn's-Like Lymphoid Reaction to Colorectal Cancer-Tertiary Lymphoid Structures With Immunologic and Potentially Therapeutic Relevance in Colorectal Cancer.
    Maoz A; Dennis M; Greenson JK
    Front Immunol; 2019; 10():1884. PubMed ID: 31507584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posttransplant Tertiary Lymphoid Organs.
    Ruddle NH
    Transplantation; 2024 May; 108(5):1090-1099. PubMed ID: 37917987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 12-CK Score: Global Measurement of Tertiary Lymphoid Structures.
    Li R; Berglund A; Zemp L; Dhillon J; Putney R; Kim Y; Jain RK; Grass GD; Conejo-Garcia J; Mulé JJ
    Front Immunol; 2021; 12():694079. PubMed ID: 34267760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tertiary lymphoid structures in cancer: maturation and induction.
    Chen Y; Wu Y; Yan G; Zhang G
    Front Immunol; 2024; 15():1369626. PubMed ID: 38690273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STINGing the Tumor Microenvironment to Promote Therapeutic Tertiary Lymphoid Structure Development.
    Filderman JN; Appleman M; Chelvanambi M; Taylor JL; Storkus WJ
    Front Immunol; 2021; 12():690105. PubMed ID: 34054879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tertiary lymphoid structures in cancer.
    Schumacher TN; Thommen DS
    Science; 2022 Jan; 375(6576):eabf9419. PubMed ID: 34990248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tertiary lymphoid structures improve immunotherapy and survival in melanoma.
    Cabrita R; Lauss M; Sanna A; Donia M; Skaarup Larsen M; Mitra S; Johansson I; Phung B; Harbst K; Vallon-Christersson J; van Schoiack A; Lövgren K; Warren S; Jirström K; Olsson H; Pietras K; Ingvar C; Isaksson K; Schadendorf D; Schmidt H; Bastholt L; Carneiro A; Wargo JA; Svane IM; Jönsson G
    Nature; 2020 Jan; 577(7791):561-565. PubMed ID: 31942071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-Associated Tertiary Lymphoid Structures: From Basic and Clinical Knowledge to Therapeutic Manipulation.
    Domblides C; Rochefort J; Riffard C; Panouillot M; Lescaille G; Teillaud JL; Mateo V; Dieu-Nosjean MC
    Front Immunol; 2021; 12():698604. PubMed ID: 34276690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous Melanoma: Mutational Status and Potential Links to Tertiary Lymphoid Structure Formation.
    Salem D; Chelvanambi M; Storkus WJ; Fecek RJ
    Front Immunol; 2021; 12():629519. PubMed ID: 33746966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial: Immune Outposts on the Inflammatory Frontier: Tertiary Lymphoid Structures as Targets for Immunotherapy of Cancer and Autoimmunity.
    Silina K; Kroeger D
    Front Immunol; 2019; 10():993. PubMed ID: 31130966
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumor-Associated Tertiary Lymphoid Structures: A Cancer Biomarker and a Target for Next-generation Immunotherapy.
    Dieu-Nosjean MC
    Adv Exp Med Biol; 2021; 1329():51-68. PubMed ID: 34664233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer Immunotherapies: From Efficacy to Resistance Mechanisms - Not Only Checkpoint Matters.
    Wang S; Xie K; Liu T
    Front Immunol; 2021; 12():690112. PubMed ID: 34367148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Induction of Tertiary Lymphoid Structures in Cancer Through Stromal Remodeling.
    Johansson-Percival A; Ganss R
    Front Immunol; 2021; 12():674375. PubMed ID: 34122434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tertiary lymphoid organs are associated with the progression of kidney damage and regulated by interleukin-17A.
    Luo R; Cheng Y; Chang D; Liu T; Liu L; Pei G; Zhang N; Wang Z; Guo K; Chen W; Li M; Fan L; Zhang C; Li Y; Dai W; Zuo M; Xu Y; Yao Y; Ge S; Xu G
    Theranostics; 2021; 11(1):117-131. PubMed ID: 33391465
    [No Abstract]   [Full Text] [Related]  

  • 19. Tertiary Lymphoid Structures as a Predictive Biomarker of Response to Cancer Immunotherapies.
    Trüb M; Zippelius A
    Front Immunol; 2021; 12():674565. PubMed ID: 34054861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Endothelial Venules: A Vascular Perspective on Tertiary Lymphoid Structures in Cancer.
    Vella G; Guelfi S; Bergers G
    Front Immunol; 2021; 12():736670. PubMed ID: 34484246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.